Market Expansion:
Public disclosures show the site network rising from 5,500+ in September 2025 to 6,000+ across 50+ countries with 25+ sponsors by 2026, indicating steady expansion. Partnerships that add distribution—such as the RealTime eClinical tie-up covering 50+ networks and 2,000+ sites—further broaden reach.
Innovation-Driven Growth:
In 2025 the company launched AI patient pre-screening and AI site-selection to accelerate enrollment and improve selection, with 2026 content highlighting added integrations and case studies. The CEO characterized these capabilities as the “biggest boost” to growth.
Investor Backing & Capital Strength:
In March 2023 the company raised a $20M Series A2 to fund product innovation, international growth, and hiring. This capital base supports continued go-to-market and platform expansion.
